Philips Q2 Sales Rise 4%, Lifts Profit Outlook on $186M Tariff Refund
PHG is trading near its 52-week low of $25.1 (0.7% above the low) on elevated volume (3.9× avg).
Summary
Philips posted Q2 comparable sales growth of 4% to EUR 4.4 billion, with all segments contributing. Order intake slipped 1% due to timing of large Connected Care orders shifting into Q3, but Europe delivered strong double-digit order growth. Adjusted EBITA margin jumped to 16.4%, boosted by a EUR 186 million US tariff refund that added 4.2 percentage points. Excluding the refund, margin was flat as inflation and tariffs offset higher sales and productivity gains. The company reiterated its full-year comparable sales growth outlook and raised its Adjusted EBITA and free cash flow guidance to reflect the tariff refund. This follows a strong Q1 and recent strategic wins, including a seven-year alliance with WellSpan Health and FDA clearance for its AI-powered ultrasound system. The tariff refund provides a one-time lift, but underlying margin pressure from inflation and tariffs remains a watchpoint. The stock trades near its 52-week low, so the raised guidance could spark a relief rally.
At the time of this announcement, PHG was trading at $25.29 on NYSE in the Life Sciences sector, with a market capitalization of approximately $25.6B. The 52-week trading range was $25.10 to $33.44. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.